Recursion Pharmaceuticals (NASDAQ: RXRX) is doing so specifically within the biotech niche, but the company's efforts haven't ...

AI companies are increasingly worried that autonomous systems could improve themselves faster than humans can safely monitor ...

AI, accelerated by systems such as Mythos, is beginning to transform into a strategic weapon surpassing nuclear arms.

AI, accelerated by systems such as Mythos, is beginning to transform into a strategic weapon surpassing nuclear arms.

OpenAI is offering a $445,000 research role focused on self-improving AI systems, and the job listing has generated serious ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

From unreliable narrators to collapsed timelines, these 25 films hide their real meaning in plain sight — and reveal it fully ...

Key factors driving this growth include the increasing need to lower drug development costs and timelines, the rising ...

Transformer Weekly: SB 315, Anthropic’s mega valuation, and the Pope talks AI ...

A correlative workflow combining cryo-electron microscopy and cryo-electron tomography with secondary ion mass spectrometry generates spatially registered chemical maps from the same vitrified sample, ...

A standardized, realistic phantom dataset consisting of ground-truth annotations for six diverse molecular species is provided as a community resource for cryo-electron-tomography algorithm ...